Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Kitanaka

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Management of advanced-phase chronic myeloid leukemiaAkira Kitanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 18, 2012
[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 4. The molecular pathogenesis of myelofibrosis]Akira Kitanaka, Kazuya Shimoda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 28, 2016
[Hematologic Malignancies/Pediatric Malignancies. II. Treatment of Essential Thrombocythemia--The Role of Anagrelide]Akira Kitanaka, Kazuya Shimoda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Molecular pathology and treatment for primary myelofibrosis]Akira Kitanaka, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Molecular biology and new drug therapy for myeloproliferative neoplasm]Akira Kitanaka, Kotaro Shide, Kazuya Shimoda
Journal of Personalized Medicine|September 26, 2025
Characteristics of Myelodysplastic Syndrome with Coagulation Abnormalities and Tailored Diagnosis and TreatmentOsamu Imataki, Makiko Uemura, Akira Kitanaka
Oxford Medical Case Reports|April 16, 2026
A mulberry in female hypertrophic cardiomyopathyOsamu Imataki, Keiko Maekawa, Masayo Tamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2014
[Clinical aspects of primary myelofibrosis in Japan]Kazuya Shimoda, Katsuto Takenaka, Akira Kitanaka, et al.
Cancer Letters|December 15, 2007
Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell linesNaoto Ichihara, Yoshitsugu Kubota, Akira Kitanaka, et al.
Annals of Clinical Biochemistry|February 11, 2010
Automated assay for determining cellular cholesterol using a random access chemistry analyserSatoshi Tada, Akira Kitanaka, Yoshitsugu Kubota, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2016
Management of advanced-phase chronic myeloid leukemiaAkira Kitanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 18, 2012
[Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 4. The molecular pathogenesis of myelofibrosis]Akira Kitanaka, Kazuya Shimoda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 28, 2016
[Hematologic Malignancies/Pediatric Malignancies. II. Treatment of Essential Thrombocythemia--The Role of Anagrelide]Akira Kitanaka, Kazuya Shimoda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Molecular pathology and treatment for primary myelofibrosis]Akira Kitanaka, Kazuya Shimoda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 26, 2013
[Molecular biology and new drug therapy for myeloproliferative neoplasm]Akira Kitanaka, Kotaro Shide, Kazuya Shimoda
Journal of Personalized Medicine|September 26, 2025
Characteristics of Myelodysplastic Syndrome with Coagulation Abnormalities and Tailored Diagnosis and TreatmentOsamu Imataki, Makiko Uemura, Akira Kitanaka
Oxford Medical Case Reports|April 16, 2026
A mulberry in female hypertrophic cardiomyopathyOsamu Imataki, Keiko Maekawa, Masayo Tamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 2014
[Clinical aspects of primary myelofibrosis in Japan]Kazuya Shimoda, Katsuto Takenaka, Akira Kitanaka, et al.
Cancer Letters|December 15, 2007
Inhibition of Src reduces gemcitabine-induced cytotoxicity in human pancreatic cancer cell linesNaoto Ichihara, Yoshitsugu Kubota, Akira Kitanaka, et al.
Annals of Clinical Biochemistry|February 11, 2010
Automated assay for determining cellular cholesterol using a random access chemistry analyserSatoshi Tada, Akira Kitanaka, Yoshitsugu Kubota, et al.
Pageof 8